South America ECMO Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates) 

No. of Pages: 112
Report Code: BMIRE00027974
Category: Life Sciences
South America ECMO Market

The South America ECMO market is expected to grow from US$ 53.00 million in 2022 to US$ 60.58 million by 2028. It is estimated to record a CAGR of 2.3% from 2022 to 2028.

 

Growing Adoption of ECMO in Lung Transplantation Procedures Bolsters South America ECMO Market Growth

Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. ECMO is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge in patient undergoing lung transplantation. Therefore, the adoption of ECMO during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, ECMO is used penultimately in treating PGD post lung transplantation. Thus, the demand for ECMO equipment is growing for treating the patients suffering from PGD.

 

South America ECMO Market Overview

 

The South America ECMO market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the market in 2022. According to World Heart Federation, noncommunicable diseases such as cardiovascular disease accounts for 74% of total deaths in Brazil. According to Global Burden Study (GBD) and Brazilian Unified Health System, cardiovascular disease was the leading cause of death in Brazil in 2019. Due to the increasing aging population in Brazil, the prevalence of cardiovascular diseases is increasing each year. According to GBD, the number of ischemic heart disease (IHD) cases reached 4 million in 2019. Further, about 171,246 deaths were reported due to IHD, which accounted for 43% of cardiovascular deaths and 12% of total deaths in Brazil in 2019. Thus, growing cardiovascular disease cases in Brazil are driving the ECMO market growth in the country.

 

South America ECMO Market Revenue and Forecast to 2028 (US$ Million)

SAM ECMO Market Revenue and Forecast to 2028 (US$ Million)

South America ECMO Market Segmentation  

 

The South America ECMO market is segmented based on modality, application, age group, and country.    

 

Based on modality, the South America ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.

 

Based on application, the South America ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.

 

Based on age group, the South America ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.   

 

Based on country, the South America ECMO market has been categorized into Brazil, Argentina, and the Rest of South America. Our regional analysis states that Brazil dominated the market in 2022.          

 

ABIOMED Inc, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the South America ECMO market.

South America ECMO Market Strategic Insights

global-market-strategic-framework
Get more information on this report

South America ECMO Market Segmentation Analysis

South America ECMO Market Report Highlights

South America ECMO Report Scope

Report Attribute Details
Market size in 2022 US$ 53.00 Million
Market Size by 2028 US$ 60.58 Million
CAGR (2022 - 2028) 2.3%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Modality
  • Venoarterial ECMO
  • Venovenous ECMO
  • Arteriovenous ECMO
By Application
  • Respiratory
  • Cardiology
By Age Group
  • Adults
  • Pediatrics
  • Neonates
Regions and Countries Covered
South and Central America Brazil, Argentina, Rest of South and Central America
Market leaders and key company profiles
  • ABIOMED Inc
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Terumo Group
Get more information on this report

South America ECMO Market Country and Regional Insights

south-america-ecmo-market
Get more information on this report
The List of Companies - South America ECMO Market
  1. ABIOMED Inc
  2. Braile Biomedica
  3. Fresenius Medical Care AG & Co KGaA
  4. Getinge AB
  5. LivaNova Plc 
  6. Medtronic Plc
  7. MicroPort Scientific Corporation  
  8. Nipro Medical Corporation   
  9. Terumo Group  
Frequently Asked Questions
How big is the South America ECMO Market?

The South America ECMO Market is valued at US$ 53.00 Million in 2022, it is projected to reach US$ 60.58 Million by 2028.

What is the CAGR for South America ECMO Market by (2022 - 2028)?

As per our report South America ECMO Market, the market size is valued at US$ 53.00 Million in 2022, projecting it to reach US$ 60.58 Million by 2028. This translates to a CAGR of approximately 2.3% during the forecast period.

What segments are covered in this report?

The South America ECMO Market report typically cover these key segments-

  • Modality (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO)
  • Application (Respiratory, Cardiology)
  • Age Group (Adults, Pediatrics, Neonates)

What is the historic period, base year, and forecast period taken for South America ECMO Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America ECMO Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South America ECMO Market?

    The South America ECMO Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ABIOMED Inc
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Terumo Group
  • Who should buy this report?

    The South America ECMO Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America ECMO Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Sales Assistance
    +1 646 791 7070 (US & UK)
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)